RBC Capital cuts ADC Therapeutics stock rating on trial results

Markets Investing.com By Investing.com 04 Jun 2026 08:01 1 min read

RBC Capital cuts ADC Therapeutics stock rating on trial results

RBC Capital cuts ADC Therapeutics stock rating on trial results

RBC Capital cuts ADC Therapeutics stock rating on trial results

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.